The following table presents the reconciliation of significant segment information reviewed by the CODM to consolidated net loss:


	Three Months Ended March 31,
	2026		2025
Total revenues (1)	$	36,415	$	30,333

Less:
Costs of goods sold and services	20,849		15,495
Certain operating expenses (2)	37,093		41,204
Other segment items (3)	(3,986)		(5,862)
Consolidated net loss	$	(17,541)	$	(20,504)

(1)Revenue generated from contracts outside of ASC 606 was not material for the three months ended March 31, 2026 and 2025.

(2)Consists of research and development and selling, general and administrative expenses from the Consolidated Statements of Operations.

(3)Other segment items represent discrete events, non-recurring transactions, or insignificant items that are not used by the CODM to evaluate the Company’s performance or allocate resources, and include:

a.Impairment and restructuring costs – impairment charges for IPR&D, goodwill, and other long-lived assets, and costs associated with approved restructuring plans, including employee separation costs and any associated costs related to implementing a restructuring plan, and vacant leased facilities;

b.Change in fair value of contingent liabilities – changes in the fair value of contingent payments as a result of updated valuation inputs;

c.Interest income – interest earned on cash, cash equivalents, and marketable securities, and the accretion of discounts on marketable securities;

d.Other income, net – gains and losses on foreign currency, and other non-recurring items that are not a part of the Company’s core business operations; and

e.Income tax benefit (expense) – income taxes related to federal, state, and foreign jurisdictions in which the Company conducts business.